Schering-Plough Reduced OTC Sales Forecast Due To GMP Problems
This article was originally published in The Tan Sheet
Executive Summary
Certain OTC products manufactured by Schering-Plough will see reduced sales due to a problematic manufacturing process and control issues cited by FDA, the company said.